跳至主要内容
临床试验/ITMCTR2000004000
ITMCTR2000004000尚未招募1 期

Clinical study on the precise diagnosis and treatment of nonalcoholic fatty liver disease with Trinity therapy combined with fibrotouth Technology

Shanghai Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 55(—)
性别
All

入选标准

  • 1) Patients with nonalcoholic fatty liver disease who meet the above diagnostic criteria of Western medicine.
  • 2) Aged between 18-55 years old, can adhere to the treatment, no allergy to traditional Chinese medicine.
  • 3) Patients with good compliance and complete clinical data required for follow-up.

排除标准

  • 1) The patients with drinking history or alcohol equivalent alcohol volume less than 40g per week;
  • 2) Those aged less than 18 years or more than 65 years;
  • 3) Women who are lactating or pregnant or planning to be pregnant;
  • 4) Those who need long-term medication for hypertension, diabetes, heart disease and blood system diseases;
  • 5) Serum transaminase (alt, AST) increased at 80u /L;
  • 6) Patients with viral hepatitis, drug-induced liver disease, Wilson's disease, total parenteral nutrition and autoimmune liver disease;
  • 7) Patients who have received other related drug treatment.

研究者

发起方
Shanghai Hospital of Traditional Chinese Medicine

相似试验

Clinical study on the precise diagnosis and... | 临床试验